Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: ASM

As I had noted before, that table does NOT explain:

GF 809,700 shares beneficially owned

CJ 525,000 shares beneficially owned

But it does confirm that, as of that date, all CF's beneficial ownership was in unexercised options (900,000)/

However, CJ & GF will have options from earlier, including I think some that expire in 2015.

Everywhere I look (NASDAQ, Google finance, Yahoo finance etc) I see no "Insiders" listed - which I really don't understand unless all 3 of them own no shares yet. An that still doesn't explain why Leckrone isn't a de facto Insider based on his knowing more about PTSC's future than just about anyone.

Share
New Message
Please login to post a reply